Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

Inclusion Criteria

• •Subjects who completed GHLiquid-1519.
• •If the subject has a history of treatment for a tumor of pituitary or peripheral site, two years or more have to be passed since completion of surgery, radiotherapy or other treatment, and recurrence of the underlying disease to be excluded.
• •Appropriate replacement therapy has been administered for more than 24 weeks for the treatment of other pituitary hormone deficiencies.